Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3767618013 | Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3767619017 | Physostigmine- and pilocarpine-containing product in ocular dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Physostigmine- and pilocarpine-containing product in ocular dose form | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Some | ||
Physostigmine- and pilocarpine-containing product in ocular dose form | Is a | Physostigmine- and pilocarpine-containing product | true | Inferred relationship | Some | ||
Physostigmine- and pilocarpine-containing product in ocular dose form | Is a | Physostigmine-containing product in ocular dose form | true | Inferred relationship | Some | ||
Physostigmine- and pilocarpine-containing product in ocular dose form | Plays role | Antiglaucoma therapeutic role | true | Inferred relationship | Some | ||
Physostigmine- and pilocarpine-containing product in ocular dose form | Is a | Pilocarpine-containing product in ocular dose form | true | Inferred relationship | Some | ||
Physostigmine- and pilocarpine-containing product in ocular dose form | Has active ingredient | Physostigmine | true | Inferred relationship | Some | 2 | |
Physostigmine- and pilocarpine-containing product in ocular dose form | Has active ingredient | Pilocarpine | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Physostigmine and pilocarpine only product in ocular dose form | Is a | True | Physostigmine- and pilocarpine-containing product in ocular dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set